Market Overview

UPDATE: Compass Point Initiates Coverage on MFA Financial with Buy Rating, $8.50 PT on Good Market Position

Related MFA
Here's Why Phibro Animal Health Is Worth Buying Right Now
Phibro Animal Health (PAHC) Rides High on Solid Prospects

In a report published Monday, Compass Point analyst Jason Stewart initiated coverage on MFA Financial (NYSE: MFA) with a Buy rating and $8.50 price target.

In the report, Compass Point noted, “MFA is an internally managed mortgage REIT focused on investing in the residential mortgage backed securities (RMBS) sector. The company has one of the longer operating histories in the group and has successfully positioned the balance sheet to benefit from a recovery in housing. With 43.5% of assets invested in non-Agency RMBS (as of 2Q13) and a conservative credit reserve established, we find the current valuation at 94% of estimated book value per share (BVPS) an attractive entry point for investors. Higher interest rates remain a risk for the Agency portfolio and to a lesser extent the non-Agency portfolio, but a manageable one given the portfolio's concentration in hybrid ARM products. Our top recommendations in the group remain focused on non-Agency credit sensitive mortgage REITs. While the Fed may provide some reprieve from higher rates and wider spreads this week, it is increasingly clear the intermediate trajectory of interest rates is higher.”

MFA Financial closed on Friday at $7.31.

Latest Ratings for MFA

May 2017Wells FargoUpgradesUnderperformMarket Perform
Dec 2016Compass PointUpgradesSellNeutral
Sep 2016FBR CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for MFA
View the Latest Analyst Ratings

Posted-In: Compass Point Jason StewartAnalyst Color Initiation Analyst Ratings


Related Articles (MFA)

View Comments and Join the Discussion!